Compare Novartis AG (NVS) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Symbotic Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Symbotic Inc trades at $43.33 (market cap $5.19B). The key difference: Novartis AG is far larger — about 55.9× Symbotic Inc's market cap, and Novartis AG pays a 3.17% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals.
| NVS | SYM | |
|---|---|---|
Market Cap | $290.25B | $5.19B |
Sector | Health | Technology |
52-Week High | $168.62 | $87.30 |
52-Week Low | $113.50 | $38.57 |
Enterprise Value | $330.27B | $3.18B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
